A sweeping review of dozens of clinical trials suggests that today’s most widely used GLP-1 receptor agonist drugs produce ...

Some patients taking popular GLP-1 weight loss drugs may be able to keep the weight off while taking injections less often, ...

In this week’s STATus Report, host Alex Hogan explains why weight loss pills were so much harder to develop than injectables.

Driven by high prices, lack of insurance, and a desire to lose weight, the proliferation of fake and falsified obesity drugs is prompting public health concern. Sophie Cousins reports.

New research is taking a closer look at what can happen when people stop taking GLP-1 medications for a long period of time.

A new study finds that popular GLP-1 drugs used to treat diabetes and obesity show new promise in fighting multiple substance use disorders.

A large study of data from Veterans Affairs finds that people on GLP-1 drugs were less likely to develop substance abuse disorder or overdose.

A recent research study found that a combination of the GLP-1 receptor agonist semaglutide and bimagrumab, an antibody that ...

A new study reports that GLP-1 semaglutide medications may help reverse the effects of osteoarthritis in the joints by ...

Savannah Chrisley got a warning letter from the FDA due to claims made on her prescription weight loss website about GLP-1s, including results and more ...

New research suggests the weight-loss medications could be powerful tools in tackling substance use disorders.